|
US20020037876A1
(en)
*
|
1998-06-25 |
2002-03-28 |
Yissum Research Development Company Of Hebrew University Of Jerusalem |
Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
|
|
US6410802B1
(en)
|
1999-04-01 |
2002-06-25 |
Esperion Therapeutics, Inc. |
Methods for synthesizing ether compounds and intermediates therefor
|
|
AU2000265105A1
(en)
*
|
2000-08-02 |
2002-02-13 |
Pharmanutrients |
Methods and compositions for the prevention and treatment of syndrome x
|
|
JPWO2002024227A1
(ja)
*
|
2000-09-20 |
2004-01-29 |
協和醗酵工業株式会社 |
腫瘍細胞増殖抑制剤
|
|
CA2425311C
(en)
|
2000-10-11 |
2011-06-14 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
US7304093B2
(en)
|
2000-10-11 |
2007-12-04 |
Esperion Therapeutics, Inc. |
Ketone compounds and compositions for cholesterol management and related uses
|
|
CN1894195A
(zh)
|
2000-10-11 |
2007-01-10 |
埃斯佩里安医疗公司 |
用于控制胆固醇以及相关用途的醚化合物以及组合物
|
|
CN101426763A
(zh)
|
2000-10-11 |
2009-05-06 |
埃斯佩里安医疗公司 |
用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物
|
|
JP2004531459A
(ja)
|
2000-10-11 |
2004-10-14 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
AU2003223930A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Novo Nordisk A/S |
Pharmaceutical use of boronic acids and esters thereof
|
|
ES2625429T3
(es)
|
2003-01-23 |
2017-07-19 |
Esperion Therapeutics Inc. |
Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes
|
|
JP2007525408A
(ja)
|
2003-12-24 |
2007-09-06 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理および関連使用のためのケトン化合物および組成物
|
|
US20090018199A1
(en)
*
|
2003-12-30 |
2009-01-15 |
Syndrome X Ltd. |
Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid
|
|
KR20050118057A
(ko)
*
|
2004-04-24 |
2005-12-15 |
김상희 |
아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
|
|
US8410109B2
(en)
|
2005-07-29 |
2013-04-02 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
WO2007137864A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Eucro European Contract Research Gmbh & Co. Kg |
Use of inhibitors of pp2c for treating or preventing arteriosclerosis
|
|
US7777071B2
(en)
|
2006-08-11 |
2010-08-17 |
Ssv Therapeutics, Inc. |
Production of carnitine conjugate intermediates
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
IL181577A0
(en)
*
|
2007-02-26 |
2007-07-04 |
Jacob Bar Tana |
Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
|
|
US8481084B2
(en)
|
2007-05-23 |
2013-07-09 |
Amcol International Corporation |
Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
|
|
DE102007051339A1
(de)
*
|
2007-10-26 |
2009-04-30 |
Müller-Enoch, Dieter, Prof. Dr. |
Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptablen Salze zur Herstellung einer pharmazeutischen Zubereitung zur Behandlung und zur Vorbeugung von Dyslipidämien
|
|
EP2085082A1
(en)
*
|
2008-01-29 |
2009-08-05 |
Nutromnia S.R.L. |
Treatment of cognitive decline
|
|
SI2346837T1
(sl)
|
2008-06-26 |
2015-05-29 |
Resverlogix Corporation |
Postopki pripravljanja kinazolinonskih derivatov
|
|
US8952021B2
(en)
|
2009-01-08 |
2015-02-10 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|
|
US10478464B2
(en)
*
|
2009-01-14 |
2019-11-19 |
Kirit Shah |
Compositions and methods of use
|
|
KR101913109B1
(ko)
|
2009-03-18 |
2018-10-31 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
WO2010120534A1
(en)
*
|
2009-03-31 |
2010-10-21 |
Whitten Matthew R |
System and method for radiation therapy treatment planning using a memetic optimization algorithm
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
WO2011027257A2
(en)
|
2009-09-03 |
2011-03-10 |
Pfizer Vaccines Llc |
Pcsk9 vaccine
|
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
CA2851996C
(en)
|
2011-11-01 |
2020-01-07 |
Resverlogix Corp. |
Pharmaceutical compositions for substituted quinazolinones
|
|
US10479752B2
(en)
*
|
2011-12-08 |
2019-11-19 |
Syndromex Ltd. |
Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
JP2016507496A
(ja)
|
2012-12-21 |
2016-03-10 |
ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． |
ブロモドメイン阻害剤としての新規複素環式化合物
|
|
WO2015123291A1
(en)
|
2014-02-11 |
2015-08-20 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Pcsk9 vaccine and methods of using the same
|
|
US10111885B2
(en)
|
2015-03-13 |
2018-10-30 |
Resverlogix Corp. |
Compositions and therapeutic methods for the treatment of complement-associated diseases
|
|
EP3267989A4
(en)
|
2015-03-13 |
2018-11-07 |
Esperion Therapeutics, Inc. |
Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
|
|
MA41793A
(fr)
|
2015-03-16 |
2018-01-23 |
Esperion Therapeutics Inc |
Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
|
|
US20180092874A1
(en)
*
|
2016-10-03 |
2018-04-05 |
Lincoln Memorial University |
Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment
|
|
US11555021B2
(en)
*
|
2017-07-07 |
2023-01-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fatty acid derivatives and their use
|
|
MX2021015936A
(es)
|
2019-06-21 |
2022-04-26 |
Esperion Therapeutics Inc |
Metodos para preparar acido bempedoico y composiciones del mismo.
|